Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer therapy

Functional precision medicine for pediatric cancers

Nature Medicine volume 30, pages 940–941 (2024)Cite this article

Subjects

A small, prospective clinical study shows that ex vivo drug screening of pediatric cancer samples can identify effective therapeutic options. If validated, these findings could herald a new approach to precision medicine in this setting.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Ex vivo calling of drug hits to support decision making in the clinical treatment of individual children with cancer.

References

  1. Church, A. J. et al. Nat. Med. 28, 1581–1589 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. van Tilburg, C. M. et al. Cancer Discov. 11, 2764–2779 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Wong, M. et al. Nat. Med. 26, 1742–1753 (2020).

    Article  CAS  PubMed  Google Scholar 

  4. De La Rocha, A. et al. Nat. Med. https://doi.org/10.1038/s41591-024-02848-4 (2024).

    Article  Google Scholar 

  5. Mayoh, C. et al. Cancer Res. 83, 2716–2732 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Yadav, B. et al. Sci. Rep. 4, 5193 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Bejarano, L., Jordao, M. J. C. & Joyce, J. A. Cancer Discov. 11, 933–959 (2021).

    Article  CAS  PubMed  Google Scholar 

  8. Peterziel, H. et al. npj Precis. Oncol. 6, 94 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Children’s Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Kensington, New South Wales, Australia

    M. Emmy M. Dolman & Paul G. Ekert

  2. UNSW Centre for Childhood Cancer Research, UNSW Sydney, Kensington, New South Wales, Australia

    M. Emmy M. Dolman & Paul G. Ekert

  3. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Melbourne, Victoria, Australia

    Paul G. Ekert

  4. Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

    Paul G. Ekert

  5. Murdoch Children’s Research Institute, The University of Melbourne Department of Paediatrics, Parkville, Melbourne, Victoria, Australia

    Paul G. Ekert

Authors
  1. M. Emmy M. Dolman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul G. Ekert
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to M. Emmy M. Dolman or Paul G. Ekert.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dolman, M.E.M., Ekert, P.G. Functional precision medicine for pediatric cancers. Nat Med 30, 940–941 (2024). https://doi.org/10.1038/s41591-024-02863-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-024-02863-5

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer